Program Track: Regeneration/Tissue Engineering
Moderator: Mark A. Reynolds
Speakers: Marc L. Nevins, Massimo Simion
Advances in tissue engineering may offer solutions that resolve bone volume deficits and periodontal defects, while at the same time eliminating some of the concerns posed by current therapeutic techniques (such as the need for autogenous bone and barrier membranes). Recombinant human plateletderived growth factor-BB (rh-PDGF-BB) has been extensively used as a potent growth factor in orthopaedics and periodontics. This program will present evidence on the need for, and use of, membranes when combining particulate and block bone replacement grafts with rhPDGF-BB. Clinical cases will highlight the potential for less invasive, growth factor-enhanced, treatment regimens to reduce technical challenges, minimize surgical complications, decrease morbidity and increase success rates.
- Develop an understanding of the rationale guiding the application of tissue engineering principles to therapeutic options.
- Gain familiarity with specific techniques utilizing rhPDGF-BB for combined hard and soft tissue grafting.
- Apply principles of tissue engineering to clinical decision-making in order to achieve optimal biological and esthetic results for challenging dental implant cases.